This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Raia Hasan/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
There are four types of botulism that are associated with the bacteria, Clostridium botulinum. | There are four types of botulism that are associated with the bacteria, Clostridium botulinum. | ||
These include food, wound, infant botulism, and inhalation botulism. | These include food, wound, infant botulism, and inhalation botulism. | ||
| + | |||
| + | '''Types of Botulinum Neurotoxins''' | ||
| + | |||
| + | Botulinum Neurotoxins A is the first type of toxin to be introduced into the cosmetic world with the abbreviated name, Botox. Botox is mainly used for treating facial imperfections, muscle spasms, and other conditions like chronic migraines, dystonia, blepharospasms, diabetic neuropathy, spinal cord injury, epicondylitis incontinence, hyperhidrosis, and many more. | ||
| + | The mechanism of action for type A: Consists of a heavy chain (100 kDa) and light chain (50 kDa) which are linked together by a single disulfide bond. It is a 150- kDa molecular weight protein that inhibits the release of acetylcholine by blocking the neuromuscular communications and transmissions on motor and sympathetic nerve terminals. The heavy chain binds at the pre-synaptic surface of cholinergic neurons. They bind one way and are irreversible. Endocytosis allows for the toxin receptor- complex to be sent into the cell after binding. The botulism toxin enters the cytoplasm after the disulfide bond between the two chains is broken. The light chain interacts with SNAP-25 (needed for binding/ attachment and release of ACH from vesicles) specifically at the nerve terminal to prevent binding of acetylcholine vesicles with the cell membrane. ^6 | ||
| + | |||
| + | |||
| + | <scene name='90/909933/Type_b/1'>Botulinum Neurotoxin B</scene> is produced through the process of fermentation to block acetylcholine release for the treatment of dystonia and sialorrhea. | ||
| + | Mechanism of Action for Type B: Binds and cleaves VAMP- which is part of the protein complex that is known for docking and fusion of the presynaptic membrane to the synaptic vesicles. | ||
| + | |||
| + | |||
| + | Botulinum Neurotoxin type C: generates apoptotic cell death in cerebellar (area in the brain that is responsible for coordination and balance) neurons acting in birds mostly but can also be seen in some mammals and fish | ||
| + | |||
| + | |||
| + | Botulinum Neurotoxin type D: causes a periodic onset of the fatal disease, botulism. This occurs mostly in horses and cattle and is rarely found in humans 88. Its mechanism of action is by inhibiting the discharge of TNF from monocytes. | ||
| + | |||
| + | |||
| + | Botulinum neurotoxin type D/C: attaches and efficiently enters into the neurons that don’t have complex gangliosides. Complex glycosphingolipids are acidic glycosphingolipids that have sialic acid groups. Type D/C recognizes the sialic acid only but no other gangliosides' moieties. | ||
| + | |||
Revision as of 18:16, 1 May 2022
==Botulinum Neurotoxin
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
